Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

807
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
807
Tumor Progression02:07

Tumor Progression

7.7K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.7K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

7.2K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.2K
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

6.6K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

5.0K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

10.0K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
10.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Response of Tomicus yunnanensis (Coleoptera: Scolytinae) to infested and uninfested Pinus yunnanensis bolts.

Journal of economic entomology·2010
Same author

Construction of novel tumor necrosis factor-alpha mutants with reduced toxicity and higher cytotoxicity on human tumor cells.

Science in China. Series C, Life sciences·2010
Same author

Impact of MSW landfill on the environmental contamination of phthalate esters.

Waste management (New York, N.Y.)·2010
Same author

[Comparison of Cj1136, Cj1138 and Cj1139 genes among Campylobacter jejuni strains].

Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi·2010
Same author

Alveolar stability under different combinations of positive end-expiratory pressure and tidal volume: alveolar microscopy in isolated injured rat lungs.

Chinese medical journal·2010
Same author

[Research on permeability of landfill's body in primary compression].

Huan jing ke xue= Huanjing kexue·2010

Related Experiment Video

Updated: Mar 9, 2026

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

1.4K

Cancer Progression Prediction Using Gene Interaction Regularized Elastic Net.

Lin Zhang, Hui Liu, Yufei Huang

    IEEE/ACM Transactions on Computational Biology and Bioinformatics
    |January 6, 2017
    PubMed
    Summary

    Integrating gene measurements and interactions improves cancer outcome prediction. The new Gene Interaction Regularized Elastic Net (GIREN) model offers a more accurate and robust approach for personalized cancer therapy.

    More Related Videos

    Predictive Immune Modeling of Solid Tumors
    08:50

    Predictive Immune Modeling of Solid Tumors

    Published on: February 25, 2020

    7.6K

    Related Experiment Videos

    Last Updated: Mar 9, 2026

    Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
    03:37

    Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

    Published on: March 1, 2024

    1.4K
    Predictive Immune Modeling of Solid Tumors
    08:50

    Predictive Immune Modeling of Solid Tumors

    Published on: February 25, 2020

    7.6K

    Area of Science:

    • Genomics
    • Bioinformatics
    • Cancer Research

    Background:

    • Tumorigenesis involves diverse genomic aberrations.
    • Accurate prognostic assessment is crucial for guiding cancer therapy.
    • Integrating heterogeneous multi-omics data for prediction remains challenging.

    Purpose of the Study:

    • To develop a novel model for harmoniously integrating multi-omics data.
    • To improve prognostic assessment for cancer patients by incorporating gene interactions.
    • To enhance the accuracy and robustness of clinical outcome prediction.

    Main Methods:

    • Proposed the Gene Interaction Regularized Elastic Net (GIREN) model.
    • Integrated gene measurements and gene-gene interaction information using an elastic net formulation.
    • Employed an iterative gradient descent algorithm for regularized optimization.
    • Applied the GIREN model to human ovarian and breast cancer datasets from The Cancer Genome Atlas.

    Main Results:

    • GIREN demonstrated superior performance compared to existing algorithms (LASSO, Elastic Net, Semi-supervised PCA).
    • The model achieved higher accuracy and robustness in predicting cancer progression.
    • Performance was evaluated using median area under the curve (AUC) and interquartile range (IQR).

    Conclusions:

    • The GIREN model offers a promising approach for effective integration of gene measurement and interaction data.
    • This method enhances prognostic assessment for personalized cancer treatment strategies.
    • The findings suggest a new direction for multi-omics data integration in cancer research.